The company has a significant commercial relationship with Bazelet, which currently owes outstanding balances to the company. Bazelet filed for a temporary stay of proceedings in the Israeli District Court as part of a restructuring process. The court granted a 90-day stay and appointed managers to oversee the restructuring. The company filed a proof of claim against Bazelet for approximately NIS 29 million and is monitoring the restructuring while evaluating alternative service providers to ensure operational continuity.
In January 2025, the company entered into a distribution agreement with N.D.N. Storage and Distribution Ltd. (N.D.N.), a licensed distributor specializing in medical cannabis logistics, storage, collection, and distribution in Israel, to enhance nationwide distribution capabilities.
In Germany, the company signed a non-exclusive distribution agreement in June 2019 with a licensed distributor to market pharmaceutical-grade cannabis products; however, no distribution has occurred to date. The company and the distributor are currently evaluating strategies to enter the German medical cannabis market. The German Cannabis Act (CanG bill), enacted in February 2024 and effective April 1, 2024, legalizes medical and adult-use cannabis, affecting the market environment.
Suppliers identified in filings include Bazelet and N.D.N. Storage and Distribution Ltd.
Intercure Ltd's Comment on Supply Chain
The company has a significant commercial relationship with Bazelet, which currently owes outstanding balances to the company. Bazelet filed for a temporary stay of proceedings in the Israeli District Court as part of a restructuring process. The court granted a 90-day stay and appointed managers to oversee the restructuring. The company filed a proof of claim against Bazelet for approximately NIS 29 million and is monitoring the restructuring while evaluating alternative service providers to ensure operational continuity.
In January 2025, the company entered into a distribution agreement with N.D.N. Storage and Distribution Ltd. (N.D.N.), a licensed distributor specializing in medical cannabis logistics, storage, collection, and distribution in Israel, to enhance nationwide distribution capabilities.
In Germany, the company signed a non-exclusive distribution agreement in June 2019 with a licensed distributor to market pharmaceutical-grade cannabis products; however, no distribution has occurred to date. The company and the distributor are currently evaluating strategies to enter the German medical cannabis market. The German Cannabis Act (CanG bill), enacted in February 2024 and effective April 1, 2024, legalizes medical and adult-use cannabis, affecting the market environment.
Suppliers identified in filings include Bazelet and N.D.N. Storage and Distribution Ltd.
Sources:
Intercure Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Intercure Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
